Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 33% ± 9% | |
conventional dendritic cell | 5 studies | 25% ± 9% | |
endothelial cell | 4 studies | 21% ± 6% | |
dendritic cell | 4 studies | 39% ± 13% | |
plasmacytoid dendritic cell | 4 studies | 21% ± 5% | |
non-classical monocyte | 3 studies | 18% ± 4% | |
ciliated cell | 3 studies | 23% ± 5% | |
macrophage | 3 studies | 21% ± 4% | |
goblet cell | 3 studies | 18% ± 1% | |
intestinal crypt stem cell | 3 studies | 19% ± 5% |
Insufficient scRNA-seq data for expression of PTGES2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2696.41 | 1445 / 1445 | 100% | 31.95 | 183 / 183 |
liver | 100% | 1922.90 | 226 / 226 | 100% | 24.33 | 406 / 406 |
pancreas | 100% | 2217.88 | 328 / 328 | 100% | 32.50 | 178 / 178 |
uterus | 100% | 2369.21 | 170 / 170 | 100% | 35.00 | 459 / 459 |
brain | 100% | 3701.58 | 2638 / 2642 | 100% | 29.45 | 705 / 705 |
thymus | 100% | 3187.24 | 652 / 653 | 100% | 29.37 | 604 / 605 |
intestine | 100% | 2957.57 | 966 / 966 | 100% | 53.43 | 525 / 527 |
skin | 100% | 2383.84 | 1809 / 1809 | 100% | 31.90 | 470 / 472 |
adrenal gland | 100% | 4620.12 | 258 / 258 | 100% | 39.23 | 229 / 230 |
ovary | 99% | 1804.29 | 179 / 180 | 100% | 29.44 | 430 / 430 |
prostate | 100% | 2963.86 | 245 / 245 | 99% | 32.34 | 499 / 502 |
stomach | 100% | 2457.05 | 359 / 359 | 99% | 42.97 | 284 / 286 |
kidney | 100% | 3355.34 | 89 / 89 | 99% | 23.43 | 894 / 901 |
bladder | 100% | 2546.52 | 21 / 21 | 99% | 37.28 | 499 / 504 |
breast | 100% | 2019.06 | 458 / 459 | 99% | 23.35 | 1102 / 1118 |
lung | 99% | 1918.37 | 572 / 578 | 99% | 27.70 | 1142 / 1155 |
eye | 0% | 0 | 0 / 0 | 100% | 38.38 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 46.74 | 29 / 29 |
muscle | 100% | 5955.81 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2730.86 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 33.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.29 | 1 / 1 |
blood vessel | 100% | 1809.74 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1721.76 | 1199 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 4526.04 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 1477.78 | 764 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046903 | Biological process | secretion |
GO_0019371 | Biological process | cyclooxygenase pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006629 | Biological process | lipid metabolic process |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0043295 | Molecular function | glutathione binding |
GO_0003677 | Molecular function | DNA binding |
GO_0050220 | Molecular function | prostaglandin-E synthase activity |
GO_0016829 | Molecular function | lyase activity |
GO_0020037 | Molecular function | heme binding |
GO_0005515 | Molecular function | protein binding |
GO_0036134 | Molecular function | 12-hydroxyheptadecatrienoic acid synthase activity |
Gene name | PTGES2 |
Protein name | Prostaglandin E synthase 2 (EC 5.3.99.3) (Microsomal prostaglandin E synthase 2) Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) (Prostaglandin-H(2) E-isomerase) [Cleaved into: Prostaglandin E synthase 2 truncated form] Prostaglandin E synthase 2 |
Synonyms | PGES2 hCG_1785478 C9orf15 |
Description | FUNCTION: Isomerase that catalyzes the conversion of PGH2 into the more stable prostaglandin E2 (PGE2) (in vitro) . The biological function and the GSH-dependent property of PTGES2 is still under debate . In vivo, PTGES2 could form a complex with GSH and heme and would not participate in PGE2 synthesis but would catalyze the degradation of prostaglandin E2 H2 (PGH2) to 12(S)-hydroxy-5(Z),8(E),10(E)-heptadecatrienoic acid (HHT) and malondialdehyde (MDA) (By similarity). . |
Accessions | A0A7I2V460 A0A7I2V4L3 ENST00000678174.1 Q9H7Z7 ENST00000338961.11 ENST00000676562.1 ENST00000449878.1 ENST00000677651.1 A0A7I2V5T7 ENST00000617202.4 A0A7I2V5X6 ENST00000277462.9 X6RJ95 ENST00000677980.1 ENST00000474124.6 ENST00000679345.1 ENST00000677691.1 ENST00000678916.1 A0A7I2V308 A6NHH0 A0A7I2YQ70 |